GSK to Establish New Global R&D Centre in Cambridge to Accelerate Drug Discovery
GSK will establish a 300,000 sq. ft. global R&D centre at the Cambridge Biomedical Campus, bringing together more than 1,000 scientists to accelerate medicines discovery through closer collaboration with leading academic, clinical and biotechnology partners.
Clinical Practice | 30/07/2026 | By News Bureau
Akums Receives First UK MHRA Approval for Rivaroxaban
Rivaroxaban is an oral anticoagulant prescribed for the prevention and treatment of thromboembolic disorders, including Non-Valvular Atrial Fibrillation (NVAF), Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE) and clinically relevant cardiovascular risk reduction.
Clinical Practice | 10/02/2026 | By News Bureau | 198
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy